Author: Darcey, Valerie L ; Turner, Sara ; Milley, Lauren ; Urbanski, Nicholas ; Guo, Juen ; Hall, Kevin D ; Yang, Shanna ; Howard, Rebecca ; Herscovitch, Peter ; Chung, Stephanie T ; Gallagher, Isabelle ; Zhou, Megan S ; Courville, Amber B ; Schick, Alex ; Chi, Meible ; Yim, Eunha ; LaNoire, Melissa ; Zhai, Nan ; Stagliano, Michael
The relationship between adiposity and dopamine type-2 receptor binding potential (D2BP) in the human brain has been repeatedly studied for >20 years with highly discrepant results, likely due to variable methodologies and differing study populations. We conducted a controlled inpatient feeding study to measure D2BP in the striatum using positron emission tomography with both [18F]fallypride and [11C]raclopride in pseudo-random order in 54 young adults with a wide range of body mass index (BMI 20-44 kg/m2). Within-subject D2BP measurements using the two tracers were moderately correlated (r=0.47, p<0.001). D2BP was negatively correlated with BMI as measured by [11C]raclopride (r= -0.51; p<0.0001) but not [18F]fallypride (r=-0.01; p=0.92) and these correlation coefficients were significantly different from each other (p<0.001). Given that [18F]fallypride has greater binding affinity to dopamine type-2 receptors than [11C]raclopride, which is more easily displaced by endogenous dopamine, our results suggest that adiposity is positively associated with increased striatal dopamine tone.